A detailed history of Glenview Trust CO transactions in Jupiter Wellness, Inc. stock. As of the latest transaction made, Glenview Trust CO holds 2,000,000 shares of JUPW stock, worth $5.84 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,000,000
Previous 2,081,556 3.92%
Holding current value
$5.84 Million
Previous $6.08 Million 3.92%
% of portfolio
0.12%
Previous 0.13%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
N/A
-81,556 Reduced 3.92%
2,000,000 $5.84 Million
Q1 2024

May 14, 2024

BUY
N/A
40,000 Added 1.96%
2,081,556 $6.08 Million
Q3 2023

Nov 13, 2023

SELL
$0.37 - $1.54 $18,500 - $77,000
-50,000 Reduced 2.39%
2,041,556 $3.06 Million
Q1 2023

May 09, 2023

BUY
$0.34 - $1.05 $17,000 - $52,500
50,000 Added 2.45%
2,091,556 $920,000
Q4 2021

Feb 10, 2022

BUY
N/A
51,556 Added 2.59%
2,041,556 $1.82 Million
Q1 2021

May 12, 2021

BUY
N/A
1,990,000 New
1,990,000 $9.43 Million

Others Institutions Holding JUPW

About Jupiter Wellness, Inc.


  • Ticker JUPW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 22,095,000
  • Market Cap $64.5M
  • Description
  • Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and J...
More about JUPW
Track This Portfolio

Track Glenview Trust CO Portfolio

Follow Glenview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Trust CO with notifications on news.